Showing 141 - 160 results of 228,012 for search '(( e non decrease ) OR ( 10 ((((nn decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.64s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146

    GFP activity is decreased in DES. by Céline Portal (3876436)

    Published 2017
    “…<p><b>(a)</b> Scatterplots show that CGC number determined on histological sections (AB—PAS coloration), and GFP<sup>+</sup> (Muc5b) and Muc5ac<sup>+</sup> CGC number determined by immunofluorescence staining (anti-GFP and anti-Muc5ac antibody) decreased (n = 10 mice, 1 section per mouse, one symbol/mouse) after 10 days of BAK application (filled-in symbols) in one eye (PBS in the other, white-filled symbols) followed by 4 days without any treatment. …”
  7. 147
  8. 148
  9. 149
  10. 150

    Sleep is decreased in TBI survivors. by Bart van Alphen (12003724)

    Published 2022
    “…Sleep data for survivors is shown here. <b>(A1–3)</b> Total sleep during the day, night and total sleep shows that post-TBI is mostly decreased during the night, for up to 4 days post TBI. …”
  11. 151
  12. 152
  13. 153
  14. 154

    The Dose–Response Decrease in Heart Rate Variability: Any Association with the Metabolites of Polycyclic Aromatic Hydrocarbons in Coke Oven Workers? by Xiaohai Li (136211)

    Published 2012
    “…We determined 10 urinary PAH metabolites and HRV indices of 1333 workers using gas chromatography–mass spectrometry and a 3-channel digital Holter monitor, respectively.…”
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159

    DataSheet_1_Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.zip by Ivan J. Cohen (5783102)

    Published 2022
    “…<p>Response to immunotherapy across multiple cancer types is approximately 25%, with some tumor types showing increased response rates compared to others (i.e. response rates in melanoma and non-small cell lung cancer (NSCLC) are typically 30-60%). …”
  20. 160

    DataSheet_2_Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.zip by Ivan J. Cohen (5783102)

    Published 2022
    “…<p>Response to immunotherapy across multiple cancer types is approximately 25%, with some tumor types showing increased response rates compared to others (i.e. response rates in melanoma and non-small cell lung cancer (NSCLC) are typically 30-60%). …”